University of Pittsburgh
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).
University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.
University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,238 total, page 24 of 25
IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
NCT00177970
Epidemiology of Coronary Heart Disease in Men Aged 40 and Over
NCT00069797
Safety Study of S-CKD602 in Patients With Advanced Malignancies
NCT00177281
Development of Early Detection Signs for Gastrointestinal Cancer
NCT00633334
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
NCT00222807
Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
NCT00091962
Donors After Cardiac Death: Validating Identification Criteria
NCT00177606
Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin
NCT00177580
Early Recovery Adherence Therapy for Bipolar Alcoholics
NCT00167323
Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.
NCT00177632
Agewise Project 3: Brief Behavioral Treatment of Insomnia in Primary Care
NCT00177203
Treatment of Depression in Adults
NCT00073697
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
NCT00118508
Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
NCT00227994
Motivationally-Enhanced Brief Interpersonal Psychotherapy for Depressed Mothers of Ill Children
NCT00245193
The S.A.F.E. Study : Computer-Aided Counseling to Prevent Teen Pregnancy/Sexually Transmitted Diseases (STDs)
NCT00151151
Effect of Exercise on Prevention of Weight Gain
NCT00177502
Web-based Support for People With Schizophrenia and Their Families
NCT00177983
Treatment of Schizophrenia Through Internet-Based Psychoeducation
NCT00051233
Multi-Tracer PET Quantitation of Insulin Action in Muscle (Phase 1, Phase 2, Phase 3, Phase 4)
NCT00222885
Therapy for Depression With Co-occurring Panic or Anxiety Symptoms
NCT00051207
Donepezil HCl & Cognitive Deficits in Autism
NCT00047697
Promoting Health in People With Fibromyalgia
NCT00167271
Treatment of Depressed Adolescents With Physical Illness
NCT00446238
Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury
NCT00148239
Cognitive/Cerebrovascular Consequences of HTN Treatment
NCT00151138
Genetics of Middle Ear Disease
NCT00422136
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
NCT00177190
Coordinated Endoscopic Colorectal Cancer Screening
NCT00327457
Coordinating Center for Caregiver Intervention Trial
NCT00177489
A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
NCT00427661
Enhancing Tobacco Abstinence Following Hospitalization
NCT00222703
Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)
NCT00177619
Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study
NCT00222820
Inhaled Bicarbonate Therapy in Cystic Fibrosis
NCT00177645
Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
NCT00177216
Preference and Vegetarian Diet in Weight Loss Treatment
NCT00330629
Pharmacotherapy in Depression With Panic Spectrum
NCT00177996
Reduction of Triglycerides in Women on Hormone Replacement Therapy
NCT00023543
Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
NCT00030069
Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
NCT00177567
Pharmacological Intervention Project (Fluoxetine)
NCT00027378
Low Dose Irradiation for Small Bowel Transplant
NCT00382486
Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction
NCT00022854
Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
NCT00018902
Low-Dose Radiation to Prevent Complications of Back Surgery
NCT00018876
Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression
NCT00177528
Molecular Associations With Reproductive Failure
NCT00298116
Surgical Versus Nonsurgical Treatment for Spinal Stenosis
NCT00022776
Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders
NCT00600470
What is open in the University of Pittsburgh pipeline
160 recruiting of 1,238 indexed (13% open); 917 completed (74%).
Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pittsburgh: open-pipeline peers nationwide
Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,238 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Intermountain Health Care · 13% recruiting · 85 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
Related
What to do with this University of Pittsburgh page
1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.
- 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.